Position in LNTH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,670,747
-$1,113,705 QoQ
Shares Held
22,027
-47.4% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 97.0581558995778.ToString("F0")%
Shared 0.ToString("F0")%
None 2.9418441004222093.ToString("F0")%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026S&T Bank/PA holds $4,383,696 across 2 Drug Manufacturers - Specialty & Generic names. LNTH ranks #2 (38.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
52,485 | $2,712,949 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
This page
|
22,027 | $1,670,747 |
All Filings in LNTH
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,670,747 | 22,027 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,784,452 | 41,840 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,606,096 | 50,811 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,710,633 | 57,545 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $5,933,299 | 60,792 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,539,363 | 61,920 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,696,328 | 70,126 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,004,567 | 74,786 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,767,292 | 108,729 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,481,540 | 120,670 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,836,396 | 127,179 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||